Pharmacy spending (more from Desktop Resource, Feb. 2008)

One of the most important therapeutic classes according is going to be cancer and transplant. "In fact, its contribution to spending increases over the next three years is definitely underestimated here since our projections are based on pharmacy claims data and a large portion of the spending for cancer treatments is paid through the medical benefit," says Lon Castle, MD, senior director, department of medical and analytical affairs at Medco.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.